Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2012
08/02/2012CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012CA2825552A1 Engineering of immunoglobulin domains
08/02/2012CA2825255A1 Antibodies selective for cells presenting egfr at high density
08/02/2012CA2824927A1 Compositions containing glycosylated antibodies and uses thereof
08/01/2012EP2482212A1 Method of acquiring proteins with high affinity by computer aided design
08/01/2012EP2482071A1 Method for detecting pork in processed food and detection kit therefor
08/01/2012EP2481758A1 Human antibodies to PSCK9 for use in methods of treating particular groups of subjects (11566)
08/01/2012EP2481757A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
08/01/2012EP2481756A2 Compositions and methods for diagnosing and treating cancer
08/01/2012EP2481755A1 Antibody capable of recognizing hla class i
08/01/2012EP2481754A1 Specific binding proteins and uses thereof
08/01/2012EP2481753A1 Anti-IL-17 Antibodies
08/01/2012EP2481752A1 Modified antibody constant regions
08/01/2012EP2481425A1 Toll like receptor 3 antagonists, methods and uses
08/01/2012EP2481424A1 Improvements in or relating to treatment and prevention of hepatitis C viral infections
08/01/2012EP2480676A1 Hybrid light chain mice
08/01/2012EP2480675A1 Mice expressing alight chain with human lambda variable and mouse constant regions
08/01/2012EP2480671A1 Process for producing molecules containing specialized glycan structures
08/01/2012EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/01/2012EP2480577A1 Disulfide stabilised multivalent antibodies
08/01/2012EP2480576A1 Antagonists of pcsk9
08/01/2012EP2480575A1 Antagonists of dsg2 for treatment of cancer
08/01/2012EP2480574A2 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
08/01/2012EP2480573A1 Treating cancer by modulating mex-3
08/01/2012EP2480572A2 Neutralizing antibodies to hiv-1 and their use
08/01/2012EP2480571A1 Anti-veev humanized antibody
08/01/2012EP2480254A2 Insulin receptor binding antibodies
08/01/2012EP2480251A1 Carrier conjugates of il-23-peptides and their induced antibodies
08/01/2012EP1940465B1 Novel use of anti il-1beta antibodies
08/01/2012EP1853310B1 Anti a beta antibody formulation
08/01/2012EP1766082B1 Cog47 protein and s100beta gene polymorphism
08/01/2012EP1756584B1 Enriched pag-55-60 fraction and methods for early detection of pregnancy in ungulate animals
08/01/2012EP1747015B1 Solution phase biopanning method using engineered decoy proteins
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012EP1685159B1 Tim-3 polypeptides
08/01/2012EP1633395B1 Functionally reconstituted viral membranes containing adjuvant
08/01/2012EP1581242B1 Compositions and methods for modifying toxic effects of proteinaceous compounds
08/01/2012EP1133310B1 Artery- and vein-specific proteins and uses therefor
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102621324A Kit for immunohistochemical staining detection of colorectal cancer and application
08/01/2012CN102621323A Method for detecting 6-methylmercaptopurine
08/01/2012CN102618940A Antibody preparation method and obtained antibody and antibody database
08/01/2012CN102618939A Method for preparing and constructing Ab2 beta antibody library capable of resisting all kinds of known and unknown respiratory virus infection
08/01/2012CN102618562A Neukinase, a downstream protein of neuregulin
08/01/2012CN102618557A Recombinant avian flavivirus E protein and application thereof
08/01/2012CN102618545A Gene involved in immortalization of human cancer cell and use thereof
08/01/2012CN102618503A Hybrid tumor cell strain 1D7 capable of secreting high neutralizing activity canine distemper virus monoclonal antibody
08/01/2012CN102618502A Hybridoma cell strain capable of secreting monoclonal antibodies to quinolones and application of monoclonal antibodies thereof
08/01/2012CN102618501A Nicotinamide N-methytransferase (NNMT) protein monoclonal antibody, hybridoma cell strain and application
08/01/2012CN102617735A Antibodies against human IL17 and uses thereof
08/01/2012CN102617734A Antibody Dab-2 against FGF-2 and application thereof
08/01/2012CN102617733A Antibodies directed against amyloid-beta peptide and methods using same
08/01/2012CN102617732A Novel egg yolk antibody and preparation method for same
08/01/2012CN102617731A Porcine circovirus-resistant type 2 egg yolk antibody, and preparation method and application thereof
08/01/2012CN102617729A Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
08/01/2012CN102617710A New immune epitope for specific antibody of human new gene FAMLF, and preparation and application of antibody
08/01/2012CN102617708A T-cell death-inducing epitopes
08/01/2012CN102617703A Method for extracting exogenous expressive protein in fermentation bacteria efficiently without cracking
08/01/2012CN102617589A Artificial antigen for aflatoxin M1 and antibody prepared by same
08/01/2012CN102617516A Albuterol artificial antigens and antibodies prepared by same
08/01/2012CN102617493A Mequindox artificial antigens and antibodies prepared by same
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN101962406B Light chain and heavy chain variable regions of anti-SEB (Staphylococcal Enterotoxin B) monoclonal antibody FMU-SEB-No.2 with high affinity
08/01/2012CN101955533B Light chain and heavy chain variable regions of anti-SEB (Staphylococcal Enterotoxin B) monoclonal antibody FMU-SEB-No.1 with high neutralizing activity
07/2012
07/31/2012US8232379 Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012US8232052 Methods of selecting a dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers
07/31/2012US8232048 Hybridoma cell line producing monoclonal antibody against foot-and-mouth disease virus, the monoclonal antibody therefrom, immunoassay reagent and kit, and immunoassay method
07/31/2012US8231876 Purified antibody composition
07/31/2012US8231875 Neutralising antibody molecules having specificity for human IL-17
07/31/2012US8231874 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
07/31/2012US8231873 Methods of treatment using antibodies to Neutrokine-alpha
07/31/2012CA2471656C Antibody against fibroblast growth factor-23
07/31/2012CA2441903C Single-domain brain-targeting antibody fragments derived from llama antibodies
07/31/2012CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
07/31/2012CA2370948C Growth factor homolog zvegf4
07/31/2012CA2362896C Vascular adhesion molecules and modulation of their function
07/31/2012CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci
07/31/2012CA2293736C Synthetic antibiotics
07/26/2012WO2012100262A1 Therapeutic method using anti - ctgf antibody
07/26/2012WO2012099983A1 Nav1.7 knockout mice and uses thereof
07/26/2012WO2012099949A2 Antibody purification via affinity chromatography
07/26/2012WO2012098407A1 Anti - il1rap antibodies and their use for treating human
07/26/2012WO2012098238A1 Combination therapies and methods using anti-cd3 modulating agents and anti-il-6 antagonists
07/26/2012WO2012098124A1 Antibodies against the s100p protein for the treatment and diagnosis of cancer
07/26/2012WO2012098113A1 Il-21 ligands
07/26/2012WO2012098089A1 Binding proteins to inhibitors of coagulation factors
07/26/2012WO2012075506A3 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
07/26/2012WO2012038825A3 Methods of increasing radiosensitivity using inhibitors of trefoil factor 1 (tff1)
07/26/2012WO2012034039A3 Anti-il-1 beta antibodies and methods of use
07/26/2012WO2012031273A3 Novel modulators and methods of use
07/26/2012US20120192315 Resistance genes and proteins active against fusarium root rots, cyst nematodes and soybean sudden death syndrome and methods employing same
07/26/2012US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies
07/26/2012US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease
07/26/2012US20120191435 Method of acquiring proteins with high affinity by computer aided design
07/26/2012US20120190830 Antibody to Human Zcyto-10 Polypeptide
07/26/2012US20120190829 Antigen binding proteins capable of binding thymic stromal lymphopoietin
07/26/2012US20120190827 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
07/26/2012US20120190826 Novel antibiotic comprising an antibody mimetic, its preparation methods and uses thereof
07/26/2012US20120190631 Materials and methods relating to glycosylation
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 1494